Bernhard H. Weigl

Bernhard Weigl is currently a Principal Investigator with Intellectual Ventures/Global Good (IV/GG) and an Affiliate Professor with the Department of Bioengineering, University of Washington, where he leads work to develop highly sensitive, rapid diagnostic assays for diseases of relevance in developing countries. From 2014 to 2015, he was a Senior Technology Officer with PATH, and a Portfolio Leader for non-communicable disease diagnostics and the former Director of the Center for Point-of-Care Diagnostics for Global Health. His work focuses on diagnostic technology research and development, including strip-based immunoassays, instrument-free molecular assays, and a variety of isothermal amplification assays for low resource settings. He has led projects across the diagnostics value chain, from invention and proof of principle though product introduction and support.